Skip to content
ALNY Alnylam Pharmaceuticals, Inc.
$273.43 2.65% +7.06
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ALNY stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 34.4B
Enterprise value 34.3B
Trailing PE -77.727272727273
Forward PE -218.47542
PEG Ratio -218.47542
Enterprise to EBITDA -259.747
Enterprise to revenue 16.386
Price to book MRQ 1061.9125
Price to sales TTM 16.411436

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 2.1B
EBITDA -132146000
Diluted EPS TTM -2.61
Total Cash (MRQ) 2.8B
Current ratio (MRQ) 2.749
Operating Cash Flow (TTM) 56.6M

ALNY trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent ALNY News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.